A
ALKS
Alkermes Plc
33.02
-1.06-3.11%Pre Market: 34.41 +1.39 +4.21%05:14 04/08 EDT
OPEN/PREV CLOSE33.86/34.08
TODAY RANGE32.47-33.96
VOL4
MARKET CAP5.49B
52 WEEK RANGE25.17-36.48
AVG VOL (3M)2.41M
% TURNOVER1.29%
TURNOVER0
P/E (TTM)23.06
% RANGE4.34%
EPS(TTM)1.432
P/E(FORWARD)-47.9795
P/B3.006
BVPS10.99
DIVIDEND--
P/S3.705
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.39B
SHARES OUTSTANDING166.25M
NEXT EARNINGS04/29-05/04
FREE FLOAT163.30M
LOT SIZE1
EX-DATE11/16/2023
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
Is Alkermes (ALKS) Building a Durable Sleep-Disorder Franchise With Its Brilliance Phase 3 Bet?
Simply Wall St·4d ago
Assessing Alkermes (ALKS) Valuation After Recent Share Price Momentum
Simply Wall St·6d ago
Alkermes Narcolepsy Trials Spark Interest In Growth And Valuation Upside
TipRanks·6d ago
Alkermes management to meet with Piper Sandler
TipRanks·6d ago
TD Cowen Sticks to Their Buy Rating for Alkermes (ALKS)
Reuters·6d ago
BUZZ-U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing
Reuters·6d ago
BUZZ-U.S. STOCKS ON THE MOVE-Cal-Maine, Rivian, Alkermes
Benzinga·6d ago
Top 2 Health Care Stocks That May Implode In April
TipRanks·6d ago
Alkermes announces initiation of Brilliance Studies
TipRanks·03/31 17:30
Wall Street Analysts Are Neutral on Top Healthcare Picks
Same Industry
Name/Symbol
Change%
Price